Lilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis

New data from Eli Lilly and Company (NYSE: LLY) showed Omvoh-treated patients with moderately to severely active ulcerative ...
BMJ Open

Quality assessment of irritable bowel syndrome-related medical information on major video platforms in China: a cross-sectional study

Objective In China, a large number of health-related short videos are posted on video platforms, including educational videos ...
The American Journal of Managed Care

Updated Guidelines Refine Best Practices for Colonoscopy Bowel Prep

Today, the US Multi-Society Task Force on Colorectal Cancer (MSTFCRC) released updated guidelines for optimizing bowel preparation before colonoscopy, refining best practices from its 2014 ...
Healio

AI mobile app improves on ‘subjective’ patient-reported stool assessment in IBS

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — A smartphone app using artificial intelligence was more effective than patient reporting in ...
MedPage Today on MSN

Migraine Drug Shows Promise as IBS Treatment in Small Trial

Rimegepant is already FDA-approved for acute treatment of migraine and preventive treatment of episodic migraine in adults.
Healio

‘Clinical features alone’ sufficient to assess need for small bowel obstruction surgery

Please provide your email address to receive an email when new articles are posted on . Clinical features alone were comparable to CT imaging for determining small bowel obstruction surgery needs.
Times Online

Bowel screening expansion under way

Health Minister and Pakuranga MP Simeon Brown says the starting age for free bowel screening has been lowered from 60 to 58 ...

Eli Lilly and Company: Lilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis

Phase 3b LUCENT-URGE is the first study in inflammatory bowel disease to assess bowel urgency across three measures - severity, frequency and stool deferral time - ...